112 related articles for article (PubMed ID: 15390301)
1. "Wait and see" strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening.
Fritsch P; Kerbl R; Lackner H; Urban C
Pediatr Blood Cancer; 2004 Nov; 43(6):679-82. PubMed ID: 15390301
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous regression of localized neuroblastoma detected by mass screening.
Yamamoto K; Hanada R; Kikuchi A; Ichikawa M; Aihara T; Oguma E; Moritani T; Shimanuki Y; Tanimura M; Hayashi Y
J Clin Oncol; 1998 Apr; 16(4):1265-9. PubMed ID: 9552024
[TBL] [Abstract][Full Text] [Related]
4. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
[TBL] [Abstract][Full Text] [Related]
5. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
Hero B; Simon T; Spitz R; Ernestus K; Gnekow AK; Scheel-Walter HG; Schwabe D; Schilling FH; Benz-Bohm G; Berthold F
J Clin Oncol; 2008 Mar; 26(9):1504-10. PubMed ID: 18349403
[TBL] [Abstract][Full Text] [Related]
6. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
[TBL] [Abstract][Full Text] [Related]
7. Past and future of neuroblastoma screening in Japan.
Sawada T
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
[TBL] [Abstract][Full Text] [Related]
8. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
[TBL] [Abstract][Full Text] [Related]
9. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study.
Oue T; Inoue M; Yoneda A; Kubota A; Okuyama H; Kawahara H; Nishikawa M; Nakayama M; Kawa K
J Pediatr Surg; 2005 Feb; 40(2):359-63. PubMed ID: 15750929
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
[TBL] [Abstract][Full Text] [Related]
11. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
[TBL] [Abstract][Full Text] [Related]
12. Connatal localized neuroblastoma. The case to delay treatment.
Kerbl R; Urban CE; Lackner H; Höfler G; Ambros IM; Ratschek M; Ambros PF
Cancer; 1996 Apr; 77(7):1395-401. PubMed ID: 8608521
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening.
Tanaka M; Kigasawa H; Kato K; Ijiri R; Nishihira H; Aida N; Ohama Y; Tanaka Y
Pediatr Blood Cancer; 2010 Apr; 54(4):573-8. PubMed ID: 20049932
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma.
Cozzi DA; Mele E; Ceccanti S; Natale F; Clerico A; Schiavetti A; Dominici C
World J Surg; 2013 Feb; 37(2):459-65. PubMed ID: 23135423
[TBL] [Abstract][Full Text] [Related]
15. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
16. Pathology review of screening negative neuroblastomas: a report from the Quebec Neuroblastoma Screening Project.
Kawakami T; Monobe Y; Monforte H; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD; Triche TJ; Shimada H
Cancer; 1998 Aug; 83(3):575-81. PubMed ID: 9690552
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
18. Screening for neuroblastoma in the northern region of England. Laboratory aspects.
Seviour JA; McGill AC; Craft AW; Parker L; Bell S; Cole M; Smith J; Hawkins E; Brown J; Dale GA
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):332-6. PubMed ID: 1456399
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
Kerbl R; Urban CE; Ladenstein R; Ambros IM; Spuller E; Mutz I; Amann G; Kovar H; Gadner H; Ambros PF
Med Pediatr Oncol; 1997 Jul; 29(1):1-10. PubMed ID: 9142198
[TBL] [Abstract][Full Text] [Related]
20. [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].
Kerbl R; Urban CE; Ladenstein R; Schnellauf C; Sitzwohl C; Lackner H; Gleispach H; Fauler G; Ambros PF; Ambros IM; Rumpler S; Gadner H; Spuller E; Höfler G; Amann G; Kytir J; Mutz I
Wien Klin Wochenschr; 1996; 108(13):398-403. PubMed ID: 8766424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]